These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 34174265)

  • 41. OGDHL silencing promotes hepatocellular carcinoma by reprogramming glutamine metabolism.
    Dai W; Xu L; Yu X; Zhang G; Guo H; Liu H; Song G; Weng S; Dong L; Zhu J; Liu T; Guo C; Shen X
    J Hepatol; 2020 May; 72(5):909-923. PubMed ID: 31899205
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CD147 reprograms fatty acid metabolism in hepatocellular carcinoma cells through Akt/mTOR/SREBP1c and P38/PPARα pathways.
    Li J; Huang Q; Long X; Zhang J; Huang X; Aa J; Yang H; Chen Z; Xing J
    J Hepatol; 2015 Dec; 63(6):1378-89. PubMed ID: 26282231
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The MYC Oncogene Cooperates with Sterol-Regulated Element-Binding Protein to Regulate Lipogenesis Essential for Neoplastic Growth.
    Gouw AM; Margulis K; Liu NS; Raman SJ; Mancuso A; Toal GG; Tong L; Mosley A; Hsieh AL; Sullivan DK; Stine ZE; Altman BJ; Schulze A; Dang CV; Zare RN; Felsher DW
    Cell Metab; 2019 Sep; 30(3):556-572.e5. PubMed ID: 31447321
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Arenobufagin, a natural bufadienolide from toad venom, induces apoptosis and autophagy in human hepatocellular carcinoma cells through inhibition of PI3K/Akt/mTOR pathway.
    Zhang DM; Liu JS; Deng LJ; Chen MF; Yiu A; Cao HH; Tian HY; Fung KP; Kurihara H; Pan JX; Ye WC
    Carcinogenesis; 2013 Jun; 34(6):1331-42. PubMed ID: 23393227
    [TBL] [Abstract][Full Text] [Related]  

  • 45. SIRT1 promotes endometrial tumor growth by targeting SREBP1 and lipogenesis.
    Lin L; Zheng X; Qiu C; Dongol S; Lv Q; Jiang J; Kong B; Wang C
    Oncol Rep; 2014 Dec; 32(6):2831-5. PubMed ID: 25270091
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Aloperine induces apoptosis and G2/M cell cycle arrest in hepatocellular carcinoma cells through the PI3K/Akt signaling pathway.
    Liu JS; Huo CY; Cao HH; Fan CL; Hu JY; Deng LJ; Lu ZB; Yang HY; Yu LZ; Mo ZX; Yu ZL
    Phytomedicine; 2019 Aug; 61():152843. PubMed ID: 31039533
    [TBL] [Abstract][Full Text] [Related]  

  • 47. DAXX drives de novo lipogenesis and contributes to tumorigenesis.
    Mahmud I; Tian G; Wang J; Hutchinson TE; Kim BJ; Awasthee N; Hale S; Meng C; Moore A; Zhao L; Lewis JE; Waddell A; Wu S; Steger JM; Lydon ML; Chait A; Zhao LY; Ding H; Li JL; Purayil HT; Huo Z; Daaka Y; Garrett TJ; Liao D
    Nat Commun; 2023 Apr; 14(1):1927. PubMed ID: 37045819
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Midazolam inhibits proliferation and accelerates apoptosis of hepatocellular carcinoma cells by elevating microRNA-124-3p and suppressing PIM-1.
    Qi Y; Yao X; Du X
    IUBMB Life; 2020 Mar; 72(3):452-464. PubMed ID: 31651086
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Osthole delays hepatocarcinogenesis in mice by suppressing AKT/FASN axis and ERK phosphorylation.
    Mo Y; Wu Y; Li X; Rao H; Tian X; Wu D; Qiu Z; Zheng G; Hu J
    Eur J Pharmacol; 2020 Jan; 867():172788. PubMed ID: 31712058
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bufalin attenuates the stage and metastatic potential of hepatocellular carcinoma in nude mice.
    Zhang ZJ; Yang YK; Wu WZ
    J Transl Med; 2014 Feb; 12():57. PubMed ID: 24581171
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tanshindiol-C suppresses in vitro and in vivo hepatocellular cancer cell growth by inducing mitochondrial-mediated apoptosis, cell cycle arrest, inhibition of angiogenesis and modulation of key tumor-suppressive miRNAs.
    Zhou P; Cheng Y; Liu F; Wu K; Qiu W; Wang S
    J BUON; 2019; 24(2):622-627. PubMed ID: 31128015
    [TBL] [Abstract][Full Text] [Related]  

  • 52. DMAMCL exerts antitumor effects on hepatocellular carcinoma both in vitro and in vivo.
    Yao S; Ye J; Yin M; Yu R
    Cancer Lett; 2020 Jul; 483():87-97. PubMed ID: 32268165
    [TBL] [Abstract][Full Text] [Related]  

  • 53. FAM122A supports the growth of hepatocellular carcinoma cells and its deletion enhances Doxorubicin-induced cytotoxicity.
    Zhou Y; Shi WY; He W; Yan ZW; Liu MH; Chen J; Yang YS; Wang YQ; Chen GQ; Huang Y
    Exp Cell Res; 2020 Feb; 387(1):111714. PubMed ID: 31711919
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Berberine suppresses colon cancer cell proliferation by inhibiting the SCAP/SREBP-1 signaling pathway-mediated lipogenesis.
    Liu Y; Hua W; Li Y; Xian X; Zhao Z; Liu C; Zou J; Li J; Fang X; Zhu Y
    Biochem Pharmacol; 2020 Apr; 174():113776. PubMed ID: 31874145
    [TBL] [Abstract][Full Text] [Related]  

  • 55. TQ inhibits hepatocellular carcinoma growth in vitro and in vivo via repression of Notch signaling.
    Ke X; Zhao Y; Lu X; Wang Z; Liu Y; Ren M; Lu G; Zhang D; Sun Z; Xu Z; Song JH; Cheng Y; Meltzer SJ; He S
    Oncotarget; 2015 Oct; 6(32):32610-21. PubMed ID: 26416455
    [TBL] [Abstract][Full Text] [Related]  

  • 56. 7-Deoxynarciclasine shows promising antitumor efficacy by targeting Akt against hepatocellular carcinoma.
    Yin S; Qiu Y; Jin C; Wang R; Wu S; Liu H; Koo S; Han L; Zhang Y; Gao X; Pang X; Wang T; Yu H
    Int J Cancer; 2019 Dec; 145(12):3334-3346. PubMed ID: 31081930
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ficolin 3 promotes ferroptosis in HCC by downregulating IR/SREBP axis-mediated MUFA synthesis.
    Yuan Y; Xu J; Jiang Q; Yang C; Wang N; Liu X; Piao HL; Lu S; Zhang X; Han L; Liu Z; Cai J; Liu F; Chen S; Liu J
    J Exp Clin Cancer Res; 2024 May; 43(1):133. PubMed ID: 38698462
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Wogonin inhibits cell cycle progression by activating the glycogen synthase kinase-3 beta in hepatocellular carcinoma.
    Hong M; Almutairi MM; Li S; Li J
    Phytomedicine; 2020 Mar; 68():153174. PubMed ID: 31991293
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MicroRNA-6809-5p mediates luteolin-induced anticancer effects against hepatoma by targeting flotillin 1.
    Yang PW; Lu ZY; Pan Q; Chen TT; Feng XJ; Wang SM; Pan YC; Zhu MH; Zhang SH
    Phytomedicine; 2019 Apr; 57():18-29. PubMed ID: 30668319
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pivotal Role of Fatty Acid Synthase in c-MYC Driven Hepatocarcinogenesis.
    Jia J; Che L; Cigliano A; Wang X; Peitta G; Tao J; Zhong S; Ribback S; Evert M; Chen X; Calvisi DF
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33187130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.